AstraZeneca lacks good medicine for Chinese limbo
Pascal Soriot is stuck in a Chinese limbo. In recent months, the CEO of $205 billion drug giant AstraZeneca has seen his ...
moneycontrol.com16h
Biocon Biologics' success in biosimilars points to the future pathway for Indian pharma
With good reason. In 2003, when AstraZeneca PLC launched Crestor, its version of the statin was priced at $2.62 per pill.
The Courier-Mail15h
Scott Power: The lowdown on Sonic’s $700m German excursion
The company has recently received orders for APAS independence instruments from AstraZeneca and Bristol Myers Squibb. Power ...
The Maravi Post9h
MACRA, MAGLA date Bwaila media club on responsible gambling
LILONGWE-(MaraviPost)-The Malawi Communication Regulatory Authority (MACRA) and Malawi Gaming and Lotteries Authority (MAGLA) has emphasized the need for the media to report effectively on responsible ...
The Maravi Post14h
An order to have Chilima’s death inquiry report to go public first, is Chakwera’s leadership sign of transparency
An order to have Chilima’s death inquiry report to go public first, is Chakwera's leadership sign of transparency - The Maravi Post ...